What Changed With MoCRA?

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marks the most significant update to US FDA cosmetic Regulations since 1938. Introduced to strengthen oversight and ensure consumer safety, MoCRA transforms what was once a largely self-regulated industry into one governed by mandatory federal requirements. For the first time, cosmetic manufacturers and brand owners are legally required to register their facilities, list marketed products with the FDA, maintain safety substantiation records, and report serious adverse events. The legislation also introduces future requirements such as mandatory Good Manufacturing Practices (GMPs) and the disclosure of fragrance allergens on product labels. MoCRA brings U.S. regulations closer in line with the European Union model, increasing accountability and raising the bar for market entry. For both U.S.-based and foreign companies, MoCRA compliance is no longer optional — it’s essential for accessing and remaining in the U.S. cosmetics market.

Key MoCRA Requirements:

Why Choose Cosmereg?

US FDA Cosmetic Regulations – Compliance Guide

The United States represents one of the largest and most competitive cosmetic markets in the world. However, successfully entering this market requires more than just a high-quality product — it requires strict compliance with US FDA cosmetic regulations, which have become significantly more rigorous with the implementation of the Modernization of Cosmetics Regulation Act (MoCRA).

At Cosmereg, we support cosmetic brands, manufacturers, and private labelers in achieving full regulatory compliance for the U.S. market. Whether you're launching a new product, reviewing your labeling, or need a MoCRA-compliant US Agent, this guide will walk you through the essential steps and requirements to legally market cosmetics in the United States.

What Is a Cosmetic According to the FDA?

The US FDA cosmetic Regulations Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), a cosmetic is defined as:

“Articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body… for cleansing, beautifying, promoting attractiveness, or altering the appearance.”
This includes: 

It is important to note that if a cosmetic product makes therapeutic claims (e.g., “treats acne” or “repairs skin damage”), it may be reclassified as a OTC drug under FDA law, requiring a New Drug Application (NDA) and clinical testing. At Cosmereg, we assist in ensuring your product claims remain compliant with the appropriate regulatory category.

US FDA Cosmetic Regulations

US FDA Cosmetic Regulations:Key Federal Requirements for Cosmetic Products

Cosmetic products marketed in the United States are subject to two primary federal laws that govern their safety, labeling, and overall compliance.

 

The first is the Federal Food, Drug, and Cosmetic Act (FD&C Act) [21 USC §§321–392], which prohibits the marketing of adulterated or misbranded cosmetics. This foundational law gives the FDA authority to take enforcement action against unsafe products or those with misleading labels or claims.

 

The second is the Fair Packaging and Labeling Act (FPLA) [15 USC §§1451–1460], which focuses on transparency and consumer protection. It requires that cosmetics display accurate and meaningful information to enable consumers to make informed purchasing decisions and compare products effectively.

 

On December 29, 2022, the FD&C Act was significantly amended by the Modernization of Cosmetics Regulation Act (MoCRA) — the most substantial regulatory overhaul of the U.S. cosmetic industry since 1938. MoCRA introduces mandatory obligations such as facility registration, product listing, safety substantiation, serious adverse event reporting, and more.

 

These requirements primarily apply to the Responsible Person, typically the brand owner or manufacturer.

 

Importantly, MoCRA does not repeal existing legislation. The original provisions of the FD&C Act and the FPLA remain fully in force. Furthermore, MoCRA does not alter the regulatory status of Over-the-Counter (OTC) drugs, such as sunscreens or anti-acne treatments, nor does it change how soaps are defined and regulated under US FDA cosmetic regulations.

What Changed With MoCRA?

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marks the most significant update to US FDA cosmetic Regulations since 1938. Introduced to strengthen oversight and ensure consumer safety, MoCRA transforms what was once a largely self-regulated industry into one governed by mandatory federal requirements. For the first time, cosmetic manufacturers and brand owners are legally required to register their facilities, list marketed products with the FDA, maintain safety substantiation records, and report serious adverse events. The legislation also introduces future requirements such as mandatory Good Manufacturing Practices (GMPs) and the disclosure of fragrance allergens on product labels. MoCRA brings U.S. regulations closer in line with the European Union model, increasing accountability and raising the bar for market entry. For both U.S.-based and foreign companies, MoCRA compliance is no longer optional — it’s essential for accessing and remaining in the U.S. cosmetics market.

Key MoCRA Requirements:

California Cosmetic Regulations: –CSCP & Prop 65

While US FDA Cosmetic Regulations federal laws such as MoCRA govern cosmetic regulations across the United States, California has established itself as a leader in state-level consumer protection — often setting the standard for the rest of the country. Through legislation such as the California Safe Cosmetics Act and Proposition 65, the state imposes additional labeling, reporting, and ingredient restrictions that go beyond federal requirements. Companies selling cosmetics in California must disclose products containing ingredients known or suspected to cause cancer, birth defects, or other reproductive harm. Additionally, California mandates public reporting of certain chemical ingredients used in personal care products and restricts animal testing for cosmetics sold in the state. These laws apply regardless of where the company is based, meaning that compliance with California’s regulations is essential for any brand seeking national distribution. For many companies, aligning with California's stricter standards serves as a baseline for broader U.S. compliance and risk mitigation.

Proposition 65

California Safe Cosmetics Program (CSCP)

Our US FDA Cosmetic Compliance Services

Cosmereg provides full-service support for cosmetic compliance in the United States:

US FDA & MoCRA Compliance

Label Review & INCI Compliance

US Agent Appointment (MoCRA)

California State Compliance

Why Choose Cosmereg?

Frequently Asked Questions

Beauty products (cosmetics) do not need to be approved by the FDA before marketing. However, some of their ingredients, such as color additives, may require independent approval. Companies that produce cosmetics are now required by the new MoCRA regulations to register their establishment and list the products in the new FDA system which is replacing the former VCRP. 

Sometimes, beauty products that claim to have benefits beyond improving or altering appearance may be classed as drugs. Sunscreen is one example of this. In cases such as this, these products require FDA approval.

The FDA classifies products as cosmetics based on their intended use. The purpose of a product can be evaluated in a number of ways – through the effects described in its marketing, what customers expect from it, and even through certain ingredients. The FDA defines cosmetics as “articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body…for cleansing, beautifying, promoting attractiveness, or altering the appearance.” Some examples of products that are defined as cosmetics are:

  • Lipsticks, eye shadows, foundations and other make-up products.
  • Face and body moisturizers.
  • Hair dyes and perming solutions.
  • Body scents and perfumes.
  • Nail polish, cuticle creams, etc.

Drugs, in comparison, are products that are defined as “articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease…and articles (other than food) intended to affect the structure or any function of the body of man or other animals.” Sometimes, a product fits the criteria to be classed as both a drug and a cosmetic, based on its intended use and effects.

The FDA recognizes ‘medical devices’ and ‘dietary supplements’ as separate categories in their own right, while other products, such as soaps, are regulated by the Consumer Product Safety Commission.

Yes, Every cosmetic product sold in the U.S. must be listed with the FDA.

  • The listing must include:
    • Product name.
    • Product ingredients (including fragrances and flavors).
    • Facility information where the product is manufactured.
  • Updates must be made annually or when there are significant changes to the product.

Under the Modernization of Cosmetics Regulation Act (MoCRA), there are certain exemptions for small businesses with an average annual gross turnover of less than $1 million USD over the past three years. However, despite these exemptions, we strongly recommend listing your products to ensure transparency and compliance with FDA expectations.

The FDA does not specify the testing required for each beauty product or ingredient. However, as a manufacturer, it is your responsibility to ensure that your products are safe when used as indicated in the instructions.

Some manufacturers, particularly those who are new to the market, may believe that a product is safe because they have used it themselves without any adverse effects, or because the ingredients are all ‘natural’. This is not correct.

OTC drugs are those that can be sold without a prescription from a medical professional. In these cases, the FDA regulates the formulations and labelling of different classes of drug, rather than the individual products. The FDA develops ‘monographs’ with guidelines for their production, distribution and application. Once the monograph is developed, companies can produce and sell these drugs without FDA pre-approval, as long as they are manufactured according to the guidelines. Monographs are used to establish the safety, effectiveness and required labelling of all OTC products.

A ‘monograph’ is used to define the safe and appropriate manufacture and use of OTC drugs. It covers ingredients, doses, formulation, indications for use and how the product should be labelled. Companies can manufacture and sell these drugs without a specific product license, as long as they conform to what is stipulated in the monograph. Monographs are published in the government’s Code of Federal Regulations(CFR). The function of the FDA is to ensure that the obligations of the Federal Food, Drug and Cosmetic Act are fulfilled.

US agent is responsible of assisting foreign cosmetic manufacturer to register their establishment to the FDA and maintain communication between the manufacturers, distributors and the FDA for products inquiries and facilities inspections.

Need Help Getting Started?

We support startups, Amazon sellers, private labels, and multinational groups to confidently enter and succeed in the US cosmetics market.

Scroll to Top